A Study of Cabozantinib Compared with Placebo in Subjects with Radioiodine-Refractory Differentiated Thyroid Cancer Who Have Progressed After Prior VEGFR targeted Therapy (XL184-311)
A Study of Cabozantinib Compared with Placebo in Subjects with Radioiodine-Refractory Differentiated Thyroid Cancer Who Have Progressed After Prior VEGFR targeted Therapy (XL184-311)
Trial Category:
Other Solid Tumor
Contact(s)
Location(s)
Methodist Estabrook Cancer Center, Omaha, NE
